Skip to main content
HSCS
NASDAQ Crypto Assets

Fortitude Invests $1.0M in HeartSciences at 22% Premium, No Change to Merger Terms

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.449
Mkt Cap
$9.924M
52W Low
$1.63
52W High
$3.93
52W Position info
50% above low
Off High info
38% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HSCS sits 50% above its 52-week low of $1.63 on light trading volume (0.1× avg).

Summary

Fortitude Mining Holdings invested $1.0 million in HeartSciences at a 22% premium to market, with no adjustment to the merger consideration. The investment strengthens HeartSciences' balance sheet ahead of the expected merger closing.


Key Events · Financing and Capital Events · HSCS

  • Fortitude Invests $1.0M at Premium

    Fortitude purchased 411,522 shares at $2.43 per share, a 22% premium to the closing price on August 12, 2026, for approximately $1,000,000.

  • No Change to Merger Consideration

    The exchange ratio under the merger agreement is unchanged, and no additional shares will be issued to Fortitude's equity holders at closing as a result of the investment.

  • Fortitude Ownership Reaches 9.4%

    Following the investment, Fortitude holds approximately 9.4% of HeartSciences' outstanding common stock.

  • Working Capital Ahead of Merger

    The investment provides additional working capital and strengthens HeartSciences' balance sheet ahead of the expected closing of the proposed business combination in the second half of 2026.


Analysis · HSCS · Crypto Assets

Fortitude Mining Holdings, the merger partner, purchased 411,522 shares of HeartSciences common stock for approximately $1.0 million at $2.43 per share, a 22% premium to the closing price on the purchase date. The investment provides working capital and strengthens the balance sheet ahead of the expected merger closing. Importantly, the exchange ratio under the merger agreement is unchanged, and no additional shares will be issued to Fortitude's equity holders at closing as a result of this investment. Following the purchase, Fortitude holds approximately 9.4% of HeartSciences' outstanding shares.

At the time of this filing, HSCS was trading at $2.45 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.63 to $3.93. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSCS - Latest Insights

HSCS
Aug 19, 2026, 5:16 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $2.50
Real-time Price: $2.49 info
Change: -$0.0100 (-0.40%) info
Market Cap: $9.924M info
HSCS
Aug 19, 2026, 5:11 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $2.50
Real-time Price: $2.49 info
Change: -$0.0100 (-0.40%) info
Market Cap: $9.924M info
HSCS
Aug 19, 2026, 4:47 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $2.49 info
Change: +$0.0415 (+2%) info
Market Cap: $9.924M info
HSCS
Aug 19, 2026, 9:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.23
Real-time Price: $2.49 info
Change: +$0.260 (+12%) info
Market Cap: $9.924M info
HSCS
Aug 18, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $2.11
Real-time Price: $2.49 info
Change: +$0.3769 (+18%) info
Market Cap: $9.924M info